Novel Human Androgen Receptor Alternative Splice Variants As Biomarkers and Therapeutic Targets

The present invention relates to novel androgen receptor splice variants (AR3, AR4, AR4b, AR5 and AR8) and variants and fragments thereof which have a role in the progression of androgen independent prostate cancer. The invention further relates to compositions and methods which can be used to identify and treat prostate cancer based on these novel androgen receptor splice variants, as well as methods for screening agents which modulate the activity and/or expression of the androgen receptor splice variants. Vectors, host cells and recombinant methods for producing the same and transgenic animals are also provided.

Attached files:
US 20100068802.jpg

Patents:
US 20,100,068,802

Inventor(s): QIU YUN [US]; GUO ZHIYONG [US]; YANG XI [US]

Type of Offer: Licensing



Next Patent »
« More Biotech Patents

Share on      


CrowdSell Your Patent